BURE Company profile
Bure Equity is a situation-based investment company. It was founded in 1992 with the abolition of Sweden’s wage-earner funds. Over its 25-year history, Bure Equity has built a diversified portfolio, comprised of nine companies. The listed companies are the Cavotec engineering group, the MedCap investor in the Life Science sector, the Mycronic electronics designer, the Vitrolife medtech group, and the Xvivo Perfusion medtech company, specialising in transplantation. The Bure Equity unlisted holdings include Bure Financial Services, Bure Growth, Investment AB Bure, and Mercuri International. The Bure Equity group has traded on the NASDAQ Stockholm since 1993. The company’s share price is listed under the BURE ticker in the Mid Cap list. Follow the latest Bure Equity share price trends at Capital.com.Latest shares articles
![](https://img.capital.com/imgs/articles/384x2000x0/1350x880_-HP-_Newsquawk-light_1.png)
![Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/384x2000x0/Hero-image-bank_1.png)
![Exterior of Infosys headquarters](https://img.capital.com/imgs/articles/384x2000x0/shutterstock_2035197281_0_0.jpg)
![Tesla logo atop of a Tesla Dealership illuminated at night.](https://img.capital.com/imgs/articles/384x2000x0/shutterstock_1494516293_0.jpg)